Hope S Rugo

Dr. Rebecca Shatsky, an academic oncologist specializing in breast cancer, shares insights on biomarker testing for ER-positive metastatic cases. Prof. Francois-Clement Bidard discusses the novel applications of oral SERDs in treatment regimens. Dr. Seth Wander dives into data analyses surrounding oral SERD monotherapy and its integration with ctDNA monitoring. Dr. Hope Rugo emphasizes patient-centered care, reviewing tolerability and management strategies for oral SERDs, ensuring that clinical practices align with patient needs.